Cabot (CBT) has affirmed a quarterly dividend of $0.4725 per share, payable on September 11, 2026, to shareholders of record as of August 28, 2026. This announcement highlights the company’s current cash return policy.

Cabot’s recent dividend affirmation comes as the stock trades at $89.58, with a 90 day share price return of 17.42% and a 1 year total shareholder return of 17.42%, suggesting momentum has been building rather than fading.

If Cabot’s trend has you thinking about where else returns might come from, this could be a good moment to scan 18 top founder-led companies for your next idea.

After Cabot’s strong 90 day run, the stock still sits slightly below both analyst targets and an estimated fair value. Is that a sign of lingering market caution, or a small gap that can close quickly?

Most Popular Narrative: 1% Overvalued

Cabot’s most followed narrative pegs fair value at $88.50, slightly below the last close at $89.58, which hints at a relatively tight valuation gap.

Battery Materials is growing quickly, supported by 43% year over year revenue growth and trailing 12 month EBITDA margins of about 24%. If this high margin, higher growth part of Cabot continues to scale while the market prices the business on more of a specialty materials profile, the share price could trend higher instead of staying flat as earnings and cash flow expand.

Want to see what sits behind that battery materials story for Cabot? The narrative leans on measured revenue growth, rising margins and a reset earnings multiple that has to line up just right.

Result: Fair Value of $88.50 (ABOUT RIGHT)

However, there are still risks to the Cabot story, including weak global carbon black fundamentals and uncertainty around execution in battery materials, which could challenge the current narrative.

Another View on Cabot’s Valuation

The first fair value story for Cabot leans on analyst earnings forecasts and a target of $88.50, which puts the stock roughly in line with those assumptions. On a simple earnings multiple, though, Cabot trades on a P/E of 16.5x, compared with 26x for the wider US Chemicals industry and 29.9x across peers, while the fair ratio sits at 21.4x. That gap points to a stock the market is pricing more cautiously than both its sector and the level our fair ratio suggests it could move toward. The question is whether that caution reflects real risk or a potential opportunity.

Next Steps

If Cabot’s mix of potential risks and rewards has you undecided, it makes sense to quickly review the full picture and shape your own view with 4 key rewards and 1 important warning sign

Looking for more investment ideas beyond Cabot?

If Cabot has sharpened your focus on opportunities, do not stop here. Broaden your watchlist with fresh ideas filtered by quality, income potential and resilience using the Simply Wall Street Screener.

• Target resilient companies that aim to protect your downside by checking out 82 resilient stocks with low risk scores as a starting universe.
• Hunt for strong fundamentals and healthier balance sheets with the solid balance sheet and fundamentals stocks screener (49 results) to see which stocks stand up to closer scrutiny.
• Spot potential value opportunities by scanning 47 high quality undervalued stocks before the crowd shifts attention to them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.